MycoLogics, Inc. Expands MycoDetect Suite of Antifungal Compound Identification Screening Services

MycoLogics, Inc., today announced the availability of MycoDetect, a comprehensive screening service used to identify active antifungal compounds.

DENVER, CO (PRWEB) September 17, 2004 -- MycoLogics, Inc., an innovative biotechnology company specializing in the development of novel drugs and vaccines for the prevention and treatment of infectious diseases, today announced the availability of MycoDetect, a comprehensive screening service used to identify active antifungal compounds.

The unique problems posed by the need for novel antifungal drugs call for the exploration of new biological sources of compounds. Now previously unexplored sources of potential bioreactive compounds may be screened for antifungal activity utilizing the new MycoDetect system of whole-cell and in vitro enzyme assays. The applied preeminent expertise of MycoLogics of identifying fungal cell wall targets combined with unique libraries of candidates will allow MycoDetect to quickly reveal lead compound strategies. The MycoDetect identification system has successfully screened libraries for antifungal activity from such diverse sources as thermal waters, microbial mats, fumaroles, microalgae and cyanobacteria. The availability of MycoDetect permits the rapid and cost-effective screening of extracts and compounds.

Contact MycoLogics to learn more about MycoDetect

About MycoLogics, Inc.

MycoLogics, Inc. is an innovative biotechnology company specializing in the development of novel antifungal drugs and therapeutic and prophylactic vaccines against human fungal and parasitic pathogens, the discovery and isolation of novel antifungal compounds for therapeutic use, and the development of novel high throughput assays that target components of fungal cell walls. MycoLogics, Inc. is headquartered in Aurora, CO at the Fitzsimmons Colorado Bioscience Park. For more information please visit www.mycologics.com.

CONTACT INFORMATION:

Dr. Claude P. Selitrennikoff, Ph.D.

President and CEO

MycoLogics, Inc.

Colorado Bioscience Park

12635 East Montview Blvd., Suite 131

Aurora, CO 80010

Tel: (720) 859-4190

Fax: (303) 724-0861

claude.selitrennikoff@uchsc.edu

###